|

Vemurafenib in combination with cobimetinib Clinical Trials

1 actively recruiting trial

Also known as: Zelboraf in combination with Cotellic

Pipeline

Phase 2/3: 1

Top Sponsors

  • Cancer Research UK1

Indications

  • Solid Tumour1
  • Haematological Malignancy1
  • Cancer1

Other1 trial

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.